124 related articles for article (PubMed ID: 8898952)
1. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.
Bessis N; Boissier MC; Ferrara P; Blankenstein T; Fradelizi D; Fournier C
Eur J Immunol; 1996 Oct; 26(10):2399-403. PubMed ID: 8898952
[TBL] [Abstract][Full Text] [Related]
2. Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis.
Kageyama Y; Koide Y; Uchijima M; Nagata T; Yoshida A; Taiki A; Miura T; Nagafusa T; Nagano A
Arthritis Rheum; 2004 Mar; 50(3):968-75. PubMed ID: 15022341
[TBL] [Abstract][Full Text] [Related]
3. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
4. Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis.
Guéry L; Chiocchia G; Batteux F; Boissier MC; Fournier C
Gene Ther; 2001 Dec; 8(24):1855-62. PubMed ID: 11821939
[TBL] [Abstract][Full Text] [Related]
5. Toxic shock syndrome toxin-1 accelerated collagen-induced arthritis in mice.
Kageyama Y; Koide Y; Nagata T; Uchijima M; Yoshida A; Arai T; Miura T; Miyamoto C; Nagano A
J Autoimmun; 2001 Mar; 16(2):125-31. PubMed ID: 11247638
[TBL] [Abstract][Full Text] [Related]
6. Suppression of collagen induced arthritis in mice utilizing plasmid DNA encoding interleukin 10.
Miyata M; Sasajima T; Sato H; Saito A; Saito A; Iriswa A; Sato Y; Kasukawa R
J Rheumatol; 2000 Jul; 27(7):1601-5. PubMed ID: 10914840
[TBL] [Abstract][Full Text] [Related]
7. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
8. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
Stasiuk LM; Abehsira-Amar O; Fournier C
Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
[TBL] [Abstract][Full Text] [Related]
11. Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway.
Yin H; Yu M; Cheng H; Zhang F; Gao Y; Lin J; Han B; Zhu L
Neuro Endocrinol Lett; 2005 Dec; 26(6):739-44. PubMed ID: 16380673
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
14. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect on the attenuation of collagen induced arthritis in tumor necrosis factor receptor I (TNFRI) and interleukin 6 double knockout mice.
Yamaguchi N; Ohshima S; Umeshita-Sasai M; Nishioka K; Kobayashi H; Mima T; Kishimoto T; Saeki Y
J Rheumatol; 2003 Jan; 30(1):22-7. PubMed ID: 12508385
[TBL] [Abstract][Full Text] [Related]
16. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
19. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
Yoshino S
J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
[TBL] [Abstract][Full Text] [Related]
20. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
